Tradestie Institutional Equity Comparison Engine

LEXX vs ENTX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ENTX Overall Edge

ENTX Captures Institutional Edge (2โ€“1 Pillars ยท 6โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Entera Bio Ltd. Ordinary Shares (ENTX) driven by superior Growth & Margin, Options & Structure while LEXX counters with relative strength in Momentum & Technical. Fundamentally, LEXX trades at N/M Forward P/E with -3862.9% operating margin (-88.5% YoY revenue) versus ENTX at N/M Forward P/E and 0.0% operating margin (-100.0% YoY). In options structure, LEXX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ENTX sits in CONSOLIDATION (32nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
LEXX N/M vs ENTX N/M Fwd P/E
Growth & Margin Winner ENTX
Op Margin -3862.9% vs 0.0% ยท YoY -88.5% vs -100.0%
Momentum & Technical Winner LEXX
1Y +300.9% vs +10.2% ยท 52W Pos 29% vs 64%
Options & Structure Winner ENTX
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (32nd %ile IV)
LEXX NASDAQ
Lexaria Bioscience Corp. Common Stock
Pharmaceutical Preparations
$4.41
-0.68% 1D
Market Cap $9.4M
1M Return +54.2%
1Y Return +300.91%
Forward P/E N/M
Unified AI Score
33.3 / 100 SELL
Tech 50.0 Fund 30.0 Flow 50.0 Mom 50.0
ENTX NASDAQ
Entera Bio Ltd. Ordinary Shares
Biological Products, (No Disgnostic Substances)
$3.02
-2.89% 1D
Market Cap $541.6M
1M Return +12.69%
1Y Return +10.22%
Forward P/E N/M
Unified AI Score
53.9 / 100 HOLD
Tech 37.0 Fund 54.0 Flow 72.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: LEXX +300.91% ENTX +10.22% Spread: +290.69 pp (LEXX Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period LEXX Revenue ENTX Revenue LEXX Op. Margin ENTX Op. Margin Margin Edge
FY2018 $0M N/A -1525.4% N/A LEXX
FY2019 $0M N/A -1868.0% N/A LEXX
FY2020 $0M $0M -1062.2% -3059.7% LEXX
FY2021 $0M $0M -786.8% -2139.6% LEXX
FY2022 $0M $0M -2591.7% -9714.2% LEXX
FY2023 $0M N/A -2888.5% N/A LEXX
FY2024 $0M $0M -1239.2% -5295.6% LEXX
FY2025 $0M $0M -1683.0% -27450.0% LEXX

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: LEXX (1) vs ENTX (6)
Institutional Metric LEXX ENTX Criterion Row Winner
Market Capitalization Scale $9.4M $541.6M Larger Scale ENTX
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -88.5% -100.0% Higher Growth LEXX
Operating Margin (TTM) Profitability -3862.9% 0.0% Higher Margin ENTX
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -162.8% -20.3% Higher ROE ENTX
52-Week Range Position Momentum 29% ($0โ€“$14) 64% ($1โ€“$4) Stronger Trend ENTX
Beta / 30D Volatility Risk Regime 11.09ฮฒ ยท 92% Vol 1.07ฮฒ ยท 46% Vol Lower Realized Risk ENTX
Unified Institutional Score Composite Signal 33.3 / 100 (SELL) 53.9 / 100 (HOLD) Higher Composite ENTX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full LEXX vs ENTX Buy Guide
LEXX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live LEXX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ENTX CONSOLIDATION
79d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 32nd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ENTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither LEXX nor ENTX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.